Filing Details

Accession Number:
0001415889-24-020108
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-25 16:33:31
Reporting Period:
2024-07-23
Accepted Time:
2024-07-25 16:33:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1730430 Kiniksa Pharmaceuticals International Plc KNSA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532218 K Sanj Patel
23 Old Bond Street, Third Floor
London X0 W1S 4PZ
Chairman & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Share Acquisiton 2024-07-23 136,124 $1.59 199,136 No 4 M Direct
Class A Ordinary Share Disposition 2024-07-23 23,075 $23.25 176,061 No 4 S Direct
Class A Ordinary Share Disposition 2024-07-23 50,000 $25.05 126,061 No 4 S Direct
Class A Ordinary Share Disposition 2024-07-23 63,049 $27.01 63,012 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Ordinary Share Share Option Disposition 2024-07-23 136,124 $0.00 136,124 $1.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
189,147 2025-12-15 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Ordinary Share 109,795 Indirect Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.
  2. This transaction was executed in multiple trades through a broker-dealer at prices ranging between $25.00 and $25.75. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  3. This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.00 and $27.07. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  4. The option is fully vested and exercisable.